...
首页> 外文期刊>Infection and immunity >The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates α1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease
【24h】

The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates α1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease

机译:铜绿假单胞菌分泌产物花青素灭活α1蛋白酶抑制剂:囊性纤维化肺病发病机理的影响。

获取原文
           

摘要

α1 Protease inhibitor (α1PI) modulates serine protease activity in the lung. Reactive oxygen species inactivate α1PI, and this process has been implicated in the pathogenesis of a variety of forms of lung injury. An imbalance of protease-antiprotease activity is also detected in the airways of patients with cystic fibrosis-associated lung disease who are infected withPseudomonas aeruginosa. P. aeruginosa secretes pyocyanin, which, through its ability to redox cycle, induces cells to generate reactive oxygen species. We tested the hypothesis that redox cycling of pyocyanin could lead to inactivation of α1PI. When α1PI was exposed to NADH and pyocyanin, a combination that results in superoxide production, α1PI lost its ability to form an inhibitory complex with both porcine pancreatic elastase (PPE) and trypsin. Similarly, addition of pyocyanin to cultures of human airway epithelial cells to which α1PI was also added resulted in a loss of the ability of α1PI to form a complex with PPE or trypsin. Neither superoxide dismutase, catalase, nor dimethylthiourea nor depletion of the media of O2 to prevent formation of reactive oxygen species blocked pyocyanin-mediated inactivation of α1PI. These data raise the possibility that a direct interaction between reduced pyocyanin and α1PI is involved in the process. Consistent with this possibility, pretreatment of α1PI with the reducing agent β-mercaptoethanol also inhibited binding of trypsin to α1PI. These data suggest that pyocyanin could contribute to lung injury in the P. aeruginosa-infected airway of cystic fibrosis patients by decreasing the ability of α1PI to control the local activity of serine proteases.
机译:α 1 蛋白酶抑​​制剂(α 1 PI)调节肺中的丝氨酸蛋白酶活性。活性氧使α 1 PI失活,这一过程与多种形式的肺损伤的发病机制有关。在患有铜绿假单胞菌的患有与囊性纤维化相关的肺部疾病的患者的气道中也检测到蛋白酶-抗蛋白酶活性的失衡。铜绿假单胞菌(P.aeruginosa)分泌黄绿素,其通过氧化还原循环的能力诱导细胞产生活性氧。我们检验了一种假设,即花青素的氧化还原循环可能导致α 1 PI失活。当α 1 PI暴露于会导致超氧化物生成的NADH和黄绿素暴露时,α 1 PI失去了与猪胰弹性蛋白酶形成抑制复合物的能力( PPE)和胰蛋白酶。类似地,在还添加了α 1 PI的人气道上皮细胞培养物中添加了花青素会导致α 1 PI形成复合物的能力丧失。 PPE或胰蛋白酶。超氧化物歧化酶,过氧化氢酶,二甲基硫脲或O 2 介质的耗尽均不能阻止活性氧的形成,从而阻止了花青素介导的α 1 PI的失活。这些数据增加了还原型花青素与α 1 PI之间直接相互作用的可能性。与这种可能性一致,用还原剂β-巯基乙醇预处理α 1 PI也抑制了胰蛋白酶与α 1 PI的结合。这些数据表明,绿脓素可能导致 P的肺损伤。通过降低α 1 PI控制丝氨酸蛋白酶局部活性的能力,铜绿感染的囊性纤维化患者的气道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号